Hoda A. Hagrass
Associate Professor
Also affiliated: Zagazig University (2012–2020); University of Arkansas Medical Center (2023–2024); The Ohio State University Wexner Medical Center (2016); The Ohio State University (2016)
Pathology, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Hoda A. Hagrass, an Associate Professor in Pathology at the University of Arkansas for Medical Sciences, studies the application of laboratory findings to clinical practice. Her research has investigated prognostic scores for severe acute liver injury and acute liver failure, examining the role of lactate dehydrogenase (LDH) and the MELD-LDH score. Hagrass has also explored temporal variations in SARS-CoV-2 seroprevalence by race and ethnicity in Arkansas, and has published case studies on the detection of Evusheld in serum protein electrophoresis and discrepancies in lactate measurements due to beta-hydroxybutyrate interference. Additionally, her work includes the investigation of plasma microRNAs as potential biomarkers for Hepatitis C virus-related hepatocellular carcinoma in Egyptian patients, and diagnostic challenges related to immunoglobulin A measurements. Her scholarly contributions are reflected in an h-index of 12 with 29 publications and 497 citations.
Metrics
- h-index: 12
- Publications: 29
- Citations: 510
Positions
-
Associate Professor 2025–presentUniversity of Arkansas for Medical Sciences Pathology, College of Medicine Institutional directory
-
Assistant professor 2019–2025University of Arkansas for Medical Sciences Medical Center Pathology ORCID
-
consultant (lecturer) 2011–2016Zagazig University Faculty of Medicine Clinical pathology department ORCID
-
Quality control supervisior 2011–2014Zagazig University Faculty of Medicine Clinical pathology depatrment ORCID
-
Assistant lecturer 2004–2011Zagazig University Faculty of Medicine Clinical Pathology department ORCID
-
post doctoral fellow 2006–2008Ohio State University comprehensive cancer centre ORCID
-
resident 2001–2004Zagazig University Faculty of Medicine Clinical Pathology Department ORCID
-
intren 2000–2001Zagazig University Faculty of Medicine Hospital ORCID
Selected Publications
-
A falsely low lactate: discrepancies in lactate measurement between blood gas and core laboratory instruments due to β-hydroxybutyrate interference—a case report (2025)
-
A-087 A case study on discrepancies in lactate measurement between blood gas and core laboratory instruments due to beta-hydroxybutyrate interference (2025)
-
B-084 The Hook Effect in Immunoglobulin A (IgA) Measurements: A Diagnostic Challenge – A Case Series (2025)
-
B-314 Automated Enzymatic Assay for Measuring Ethylene Glycol (2025)
-
The Hook Effect in Immunoglobulin A (IgA) Measurements: A Diagnostic Challenge—A Case Series (2025)
-
Evusheld, a SARS-CoV-2 spike protein–directed attachment inhibitor, appears in serum protein electrophoresis and immunofixation: a case study (2023)
-
LDH and the MELD-LDH in Severe Acute Liver Injury and Acute Liver Failure: Preliminary Confirmation of a Novel Prognostic Score for Risk Stratification (2023)
-
Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas (2022)
-
Plasma MicroRNAs as Biomarkers for HCV Related Hepatocellular Carcinoma: Diagnostic Performance of a microRNA Panel in Egyptian Patients (2021)
-
Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas (2021)
-
Influence of Cytokine Gene Polymorphisms on the Risk of Gastric Disorders in H. pylori Infected Patients (2020)
Collaboration Network
Top Collaborators
- Influence of Cytokine Gene Polymorphisms on the Risk of Gastric Disorders in H. pylori Infected Patients
- Plasma MicroRNAs as Biomarkers for HCV Related Hepatocellular Carcinoma: Diagnostic Performance of a microRNA Panel in Egyptian Patients
- Influence of Cytokine Gene Polymorphisms on the Risk of Gastric Disorders in H. pylori Infected Patients
- Plasma MicroRNAs as Biomarkers for HCV Related Hepatocellular Carcinoma: Diagnostic Performance of a microRNA Panel in Egyptian Patients
- Influence of Cytokine Gene Polymorphisms on the Risk of Gastric Disorders in H. pylori Infected Patients
- Plasma MicroRNAs as Biomarkers for HCV Related Hepatocellular Carcinoma: Diagnostic Performance of a microRNA Panel in Egyptian Patients
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
Similar Researchers
Based on overlapping research topics